Literature DB >> 19475785

Forecasting age-related macular degeneration through 2050.

Barbara E K Klein1, Ronald Klein.   

Abstract

Year:  2009        PMID： 19475785     DOI： 10.1001/jama.2009.729

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

Review 1.  Genetic and environmental underpinnings to age-related ocular diseases.

Authors:  Johanna M Seddon
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-13       Impact factor: 4.799

2.  Inhibition of cell proliferation, migration and apoptosis in blue-light illuminated human retinal pigment epithelium cells by down-regulation of HtrA1.

Authors:  Tian Yu; Chang-Zheng Chen; Yi-Qiao Xing
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

3.  Street-crossing decision-making: a comparison between patients with age-related macular degeneration and normal vision.

Authors:  Shirin E Hassan; Benjamin D Snyder
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-09-12       Impact factor: 4.799

Review 4.  Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review.

Authors:  Saira Khanna; Rahul Komati; David A Eichenbaum; Ishani Hariprasad; Thomas A Ciulla; Seenu M Hariprasad
Journal:  BMJ Open Ophthalmol       Date:  2019-12-15

Review 5.  New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD).

Authors:  Prem Patel; Veeral Sheth
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

6.  HTRA1 rs11200638 variant and AMD risk from a comprehensive analysis about 15,316 subjects.

Authors:  Ying Liu; Huipeng Jin; Dong Wei; Wenxiu Li
Journal:  BMC Med Genet       Date:  2020-05-15       Impact factor: 2.103

7.  NEI-Supported Age-Related Macular Degeneration Research: Past, Present, and Future.

Authors:  Charles Wright; Anna E Mazzucco; Steven M Becker; Paul A Sieving; Santa J Tumminia
Journal:  Transl Vis Sci Technol       Date:  2020-06-30       Impact factor: 3.283
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.